Minit J. Shah

Phase III randomized controlled trial of gefitinib versus chemotherapy in EGFR-positive treatment-naïve metastatic lung cancer: Long-term outcome after eight years

S. Goud, S. More, Ajay Singh, 2024, Cancer Research, Statistics, and Treatment.

Real-world analysis of BRAF inhibitors in patients with solid tumors positive for BRAF V600E mutation: A retrospective observational study

V. Noronha, V. Patil, N. Menon, 2022, Cancer Research, Statistics, and Treatment.

Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients.

V. Noronha, N. Menon, S. Limaye, 2024, Clinical lung cancer.

Cabozantinib: A narrative drug review

K. Prabhash, V. Noronha, V. Patil, 2023, Cancer Research, Statistics, and Treatment.

G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.

K. Prabhash, R. Badwe, V. Noronha, 2022, Journal of geriatric oncology.